- Allurion Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean Mass Preservation for Sustainable, Healthy Weight Loss
- Allurion Reports First Quarter 2024 Financial Results and Provides Business Update
- Allurion Announces Three Scientific Presentations at IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance Survey
- Allurion Announces Preliminary First Quarter 2024 Results
- Allurion Closes $48 Million Convertible Senior Secured Note Financing with RTW Investments
- Allurion Expands Virtual Care Suite to the United States
- Allurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
- Allurion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
- Milena Alberti-Perez Joins Allurion Board of Directors as Audit Committee Chair
- Allurion to Report Fourth Quarter 2023 Financial Results on March 21, 2024
More ▼
Key statistics
As of last trade Allurion Technologies Inc (ALUR:NYQ) traded at 1.69, 8.33% above its 52-week low of 1.56, set on Apr 01, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.69 |
---|---|
High | 1.69 |
Low | 1.69 |
Bid | 1.68 |
Offer | 1.82 |
Previous close | 1.69 |
Average volume | 84.42k |
---|---|
Shares outstanding | 47.92m |
Free float | 36.38m |
P/E (TTM) | -- |
Market cap | 80.98m USD |
EPS (TTM) | -1.37 USD |
Data delayed at least 15 minutes, as of May 21 2024 14:35 BST.
More ▼